Classification of Sneddon's syndrome

Vasa - Journal of Vascular Diseases

Volumn 26, Issue 3, 1997, Pages 215-221

  Schellong, S M ^a,b   Weissenborn, K ^a   Niedermeyer, J ^a   Wollenhaupt, J ^a   Sosada, M ^a   Ehrenheim, Ch ^a   Lubach, D ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

livedo antiphospholipid antibodies; Sneddon's syndrome; thrombophilia

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LIVEDO RETICULARIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; SNEDDON SYNDROME; THROMBOPHILIA;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; CEREBROVASCULAR DISORDERS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS; SNEDDON SYNDROME;

EID: 0030769525     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Antoine JC, Michel D, Garnier P, Genin C. Rheumatic heart disease and Sneddon's Syndrome. Stroke 1994; 25:689-91.
2. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E, Hughes GRV. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989; 86: 391-9.
3. Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94:923-7.
4. Devos J, Bulcke J, Degreef H, Michielsen B. Generalized livedo reticularis and cerebrovascular disease. Importance of hemostatic screening. Dermatol 1992; 185: 296-9.
5. Donnet A, Khalil R, Terrier G, Koeppel MC, Njee BT, Aillaud MF. Cerebral infarction, livedo reticularis, and familial deficiency in Antithrombin-III. Stroke 1992; 23: 611-2.
6. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the standardization of lupus anticoagulants. Thromb Haemostas 1991; 65: 320-2.
7. Finazzi G, Brancaccio V, Moia M, Ciavarella N, Mazzucconi MG, Schinco PC, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D'Angelo A, Palareti G, De Stefano V. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian Registry. Am J Med 1996; 100: 530-6.
8. Fleischer AB, Resnick SD. Livedo reticularis. Dermatol Clin 1990; 8: 347-54.
9. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
10. Kalashnikova LA, Nasonov EL, Borisenko VV, Usman VB, Prudnikova LZ, Kovaljov VU, Kushekbaeva AF. Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol 1991; 9: 357-61.
11. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990; 89: 411-9.
12. Levine SR, Langer SL, Albers JW, Welch KMA. Sneddon's syndrome: an antiphospholipid antibody syndrome? Neurology 1988; 38:798-800.
13. Lubach D, Schwabe C, Weissenborn K, Hartung K, Creutzig A, Drenk F. Livedo racemosa generalisata. An evaluation of 34 own case observations. J Am Acad Dermatol 1990; 22: 633-9.
14. Marsch WCL, Muckelmann R. Generalized racemosa livedo with cerebrovascular lesions (Sneddon's syndrome): An occlusive arteriolopathy due to proliferation of medial smooth muscle cells. Br J Dermatol 1985; 112: 703-8.
15. Rebollo M, Val JF, Garijo F, Berciano J. Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Brain 1983; 106: 965-79.
16. Rumpl E, Rumpl H. Recurrent transient global amnesia in a case with cerebrovascular lesions and livedo reticularis (Sneddon syndrome). J Neurol 1979; 221: 127-31.
17. Sitzer M, Söhngen D, Siebler M, Specker C, Rademacher J, Janda I, Aulich A, Steinmetz H. Cerebral microembolism in patients with Sneddon's syndrome. Arch Neurol 1995; 52: 271-5.
18. Sneddon IB. Cerebrovascular lesions and livedo reticularis. Br J Dermatol 1965; 77: 180-5.
19. Stephens CJM. Sneddon's syndrome. Clin Exp Rheumatol 1992; 10:489-92.
20. Weissenborn K, Lubach D, Schwabe C, Becker H. Sneddon's syndrome: Clinical course and outcome. J Neurol 1989; 236: 34-7.
21. Weissenborn K, Rückert N, Ehrenheim C, Schellong SM, Goetz C, Lubach D. Neuropsychological deficits in patients with Sneddon's syndrome. J Neurol 1996; 243: 357-63.
22. Zeiger B, Sepp N, Schmid KW, Hintner H, Klein G, Fritsch PO. Life history of cutaneous vascular lesions in Sneddon's syndrome. Hum Pathol 1992; 23: 668-75.
23. Zeiger B, Sepp N, Stockhammer G, Dosch E, Hilty E, Öfner D, Aichner F, Fritsch PO. Sneddon's syndrome. A long-term follow-up of 21 patients. Arch Dermatol 1993; 129: 437-47.